Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow 0.00% Nasdaq Up0.52%

More On MCUJF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Medicure Inc. (MCUJF)

-Other OTC
1.71 Down 0.07(3.99%) 2:50PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Medicure Inc.
2-1250 Waverley Street
Winnipeg, MB R3T 6C6
Canada - Map
Phone: 204-487-7412
Fax: 204-488-9823
Website: http://www.medicure.com

Details 
Index Membership:N/A
Sector:N/A
Industry:N/A
Full Time Employees:N/A

Business Summary 

Medicure Inc., a biopharmaceutical company, researches, develops, and commercializes human therapeutics in Canada, the United States, and Barbados. The company markets and sells AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It is also developing Tardoxal, which is in Phase IIa clinical trial for the treatment of tardive dyskinesia/neurological indications; and Transdermal AGGRASTAT that is in a preclinical stage for acute cardiology. In addition, the company offers novel therapeutics comprising a series of small molecule dual acting anticoagulant/antiplatelet compounds to treat venous and arterial thrombosis. Medicure Inc. was founded in 1997 and is headquartered in Winnipeg, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Medicure Inc.

Key Executives 
 PayExercised
Dr. Albert D. Friesen Ph.D., 67
Founder, Chairman and Chief Exec. Officer
189.00K0.00
Mr. Dawson J. Reimer MAFS, 43
Pres and Chief Operating Officer
168.00K0.00
Mr. James Kinley C.A., 36
Chief Financial Officer and Sec.
0.000.00
Dr. George R. Thomas M.Pharm, Ph.D.,
Director of R&D
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.